Sumampong, Noe P.
HRN: 23-09-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
OXACILLIN 500MG (VIAL)
07/03/2023
07/09/2023
IVT
263mg
Q6
Mass On Anterior Proximal Aspect Of Left Thigh; T/c Abscess; T/c Diaper Dermatitis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes